COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Brenig Therapeutics is a neurology-focused small-molecule drug developer using an AI/ML discovery platform in partnership with Expert Systems Inc., advancing BT-267, a brain-selective LRRK2 inhibitor, into clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors